OverviewChartProfileKey statisticsFinancialsTechnicalNewsTraderScreen

Halozyme Therapeutics Incorporate.../  US40637H1095  /

NASDAQ
6/24/2024  10:00:00 PM Chg. +0.5100 Volume Bid10:06:36 PM Ask10:06:36 PM High Low
52.0600USD +0.99% 1.28 mill.
Turnover: 45.22 mill.		 52.0600Bid Size: 1,900 53.0000Ask Size: 500 52.9200 51.7200

Business description

-
 

Management board & Supervisory board

CEO
Helen Torley
Management board
Nicole LaBrosse, Mark Snyder, Michael J. LaBarre, Chris Wahl, Cortney Caudill, Tram Bui, Gary Grote, Amy Fox, Steve Knowles, Christopher Bryant, Kristin Schwartzbauer
Supervisory board
Jeffrey W. Henderson, Jean-Pierre Bizzari, Barbara Duncan, Matthew L. Posard, Connie L. Matsui, Moni Miyashita, Bernadette Connaughton, Helen Torley
 

Company data

Name: Halozyme Therapeutics Inc.
Address: -,-
Phone: -
Fax: -
E-mail: -
Internet: -
Industry: Biotechnology
Sector: Biotechnology
Sub sector: Biotechnology
End of financial year: -
Free Float: -
IPO date: -

Investor relations

Name: -
IR phone: -
IR Fax: -
IR e-mail: -

Main Shareholders